In Investor Briefings, Ortho CEOs See Electives Coming Back Strong

article image

Demand for elective orthopedic surgeries is returning faster than companies or Wall Street expected, but they aren’t sure how much is driven by a bolus from delayed procedures or arrival of new patients, which would bode well for the longer term.

Elective procedures and consumer sentiment—two key recovery metrics for the medical device industry as it gauges the rate of return to pre-pandemic normalcy—are improving faster than expected after a disastrous, COVID-19-dominated late March and April.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: